Exploring patient values in medical decision making: A qualitative study by Lee, Y.K. et al.
Exploring Patient Values in Medical Decision Making: A
Qualitative Study
Yew Kong Lee1*, Wah Yun Low2, Chirk Jenn Ng1
1Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia, 2 Faculty of Medicine Dean’s Office, Faculty of Medicine,
University of Malaya, Kuala Lumpur, Malaysia
Abstract
Background: Patient decisions are influenced by their personal values. However, there is a lack of clarity and attention on
the concept of patient values in the clinical context despite clear emphasis on patient values in evidence-based medicine
and shared decision making. The aim of the study was to explore the concept of patient values in the context of making
decisions about insulin initiation among people with type 2 diabetes.
Methods and Findings: We conducted individual in-depth interviews with people with type 2 diabetes who were making
decisions about insulin treatment. Participants were selected purposively to achieve maximum variation. A semi-structured
topic guide was used to guide the interviews which were audio-recorded and analysed using a thematic approach. We
interviewed 21 participants between January 2011 and March 2012. The age range of participants was 28–67 years old. Our
sample comprised 9 women and 12 men. Three main themes, ‘treatment-specific values’, ‘life goals and philosophies’, and
‘personal and social background’, emerged from the analysis. The patients reported a variety of insulin-specific values,
which were negative and/or positive beliefs about insulin. They framed insulin according to their priorities and philosophies
in life. Patients’ decisions were influenced by sociocultural (e.g. religious background) and personal backgrounds (e.g. family
situations).
Conclusions: This study highlighted the need for expanding the current concept of patient values in medical decision
making. Clinicians should address more than just values related to treatment options. Patient values should include
patients’ priorities, life philosophy and their background. Current decision support tools, such as patient decision aids,
should consider these new dimensions when clarifying patient values.
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Introduction
Patient decisions are influenced by their personal values;
however, there is a lack of clarity and attention on the concept
of patient values in the clinical context. This is despite clear
emphasis on patient values in evidence-based medicine (EBM) and
shared decision making (SDM) [1,2,3,4]. EBM advocates that
patients and clinicians make a choice together after considering
the best available evidence, the clinician’s experience and the
patient’s values [3,5].
Current definitions of patient values are often vague (e.g. patient
values are ‘‘the features that matter most to patients [6]’’, ‘‘the
unique preferences, concerns and expectations each patient brings
to a clinical encounter and which must be integrated into clinical
decisions if they are to serve the patient’’ [1]) or too narrow. For
instance, international standards for patient decision aids narrow
the scope of value clarification methods to patient views on
physical, psychological and social effects, and the positive and
negative features that matter most to patients [7].
To date, most studies on the patient role in shared decision
making have focused on measurable patient outcomes, such as
more accurate risk assessment [8] or increased patient involvement
during consultations [9]. Little research has been conducted on
how patients actually choose between options and the patient
voice is missing from the conversation [10,11].
Previous studies have reported that values function as a filter
through which patients interpret clinical evidence [12,13,14] and
make treatment choices [12,15]. Understanding how values
influence patient decision making is particularly relevant to
preference-sensitive decisions where there are trade-offs or when
there is no one best option. Insulin initiation is one such example
of a ‘difficult’ decision which is influenced heavily by patient values
[16,17]. This is particularly important in the context of diabetes
which is reaching epidemic proportion and has significant
morbidity and mortality [18].
This study used insulin initiation as an exemplar to explore
patient values and proposed to create a new model to explain
patient values in the context of decision making. It aimed to
explore and define patient values because this may help clinicians
to understand and address patient concerns and expectations
when making decisions.
PLOS ONE | www.plosone.org 1 November 2013 | Volume 8 | Issue 11 | e80051
Methods
Ethics Statement
This study received ethics approval from the Medical Research
and Ethics Committee, Ministry of Health, Malaysia (Ref No:
NMRR-10-1233-7299) and the Medical Ethics Committee,
University of Malaya Medical Centre, Kuala Lumpur (MEC
Ref No: 841.6).
Methodological Approach
Due to the lack of literature on values from patients’ perspective,
and the exploratory nature of the study, a qualitative study design
was chosen [11]. We conducted individual semi-structured in-
depth interviews to explore each patient’s values within their
experience of insulin initiation. This study formed part of a larger
three-year project to develop a decision support tool for clinicians
and patients who are making decisions about insulin therapy.
Conceptual Framework
Our study was developed from the perspective of a SDM model.
We used the Ottawa Decision Support Framework (ODSF), an
SDM implementation framework, as the conceptual framework
within which patient values are nested [19,20]. The ODSF
identifies the decisional needs of patients as values, decisional
conflict, knowledge and expectations, support and resources,
decision characteristics, and, personal characteristics. Patient
values are defined in the ODSF as the ‘‘desirability or personal
importance of outcomes of options’’ [20]. We developed a topic
guide with 16 questions exploring two main decisional attributes:
barriers and facilitators to insulin initiation and barriers and
facilitators to decision making; the former focused on patient’s
perceptions about insulin itself, while the latter explored the
patient’s experience of the decision making process. In order to
explore in-depth the topic of values, we then incorporated
Schwartz’s theory of values, which is a psychological theory
relating to the priority and function of human values [21]. In this
theory, the five key attributes of values are: ‘‘(1) values are concepts
or beliefs; (2) values pertain to desirable end states or behaviors; (3)
values transcend specific situations; (4) values guide selection or
evaluation of behavior and event; and (5) values are ordered by
relative importance’’ [22]. Table 1 shows the seven questions in
our topic guide which explored these five attributes in the context
of insulin initiation.
Setting
This study was conducted in Malaysia, which is an upper-
middle-income, multi-cultural country comprising three main
ethnicities (Malay, Chinese and Indian) [23]. Malay is the official
language but English is widely spoken in urban areas. Malaysia has
a dual healthcare system. The public sector consists of govern-
ment-subsidized hospitals and health clinics, which serve the
majority of the population; the private sector comprises fee-for-
service hospitals and clinics. Patients are free to choose where they
prefer to receive treatment.
Malaysia has the tenth-highest prevalence rate of diabetes in the
world [24,25] and 70–80% of the Malaysian patients in the
primary care setting fail to achieve target HbA1c levels of #7.0%
[26,27]. The Malaysian clinical practice guideline recommends
insulin initiation in patients with type 2 diabetes mellitus who are
poorly controlled despite taking optimal oral glucose-lowering
drugs [28]. However, insulin uptake remains poor [24].
Sampling
Our sample included a range of patients at various stages of
decision making. Patients with type 2 diabetes who were still
considering insulin or had made a decision about insulin within
the past 1 year were included in this study. We decided on this
range considering the range of patients’ decision making times is
varied for insulin initiation. Unlike one-off medical decisions (such
as screening tests or surgery), insulin initiation is a decision that
may be considered over a prolonged period of time; patients may
change their views about insulin before, during, and after initiation
[29]. Clinicians recruited patients whom they had recently advised
to start insulin.
Purposive sampling was used whereby we recruited non-
randomized participants with specific characteristics in order to
achieve maximal variation based on three factors: healthcare
setting, patients’ decision about starting insulin, and their ethnicity.
To achieve a broad socio-demographic spectrum in the sample,
we recruited patients from public and private, as well as rural and
urban settings. We included patients who were reluctant to
initiating insulin therapy as well as patients who were motivated to
initiate insulin therapy. As the interviews progressed, we constantly
reviewed the sample characteristics and updated the clinicians on
the types of patients we were interested in.
Data Collection
An interview topic guide was developed based on literature
review, conceptual framework and expert opinion (Table 1). The
topic guide was pilot-tested and iteratively modified based on
themes that emerged during both pilot and subsequent interviews.
Both the participant information sheet and topic guide were
translated into Malay and Chinese by researchers who were fluent
in these languages. Before each interview, participants were given
an information sheet and written consent was obtained to
participate in the study.
Semi-structured in-depth interviews were conducted with
patients in their preferred language (English, Malay or Chinese).
Interviews were conducted by three researchers trained in
qualitative research methods (YK, CJ, and PY) and each lasted
30–45 minutes. Researchers arranged to interview patients at a
time and location of their convenience, including their homes or
workplaces if patients were unable to travel due to work
commitments or infirmities. Participants were reimbursed for
their time and travel. Although the patients were informed that
they would be participating in an individual interview, four were
accompanied by family members. In such instances, care was
taken to avoid having the family members dominate the discussion
by consciously focusing questions on the patient.
Data Analysis
English and Malay interviews were transcribed verbatim while
Chinese interviews were translated into English for analysis. Malay
interviews were not translated as all researchers were familiar with
the language. A thematic analysis approach was used for data
analysis, based on Strauss and Corbin’s method of open, axial and
selective codes [30]. Three researchers (YK, WY, and CJ)
independently coded two interviews line by line to develop an
initial list of codes (open coding). A process of constant comparison
was employed whereby subsequent interviews were coded using
this list and new themes which emerged from new interviews were
added to the list upon consultation with the research team. Any
discrepancies in the coding process were resolved by discussion
during monthly research meetings.
Codes were organised and re-organised into broader categories
based on thematic similarities between codes (axial coding).
Patient Values in Medical Decision Making
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Selective coding was conducted to generate central or core
categories based on connecting and consolidating axial codes. All
codes were checked by two researchers (YK, CJ) to ensure
consistency of coding and consensus on axial and selective codes.
Data collection was stopped when data saturation was reached.
Evidence of data saturation was obtained when no new axial or
selective codes emerged from the data, showing that the core
categories had already been captured. A secondary saturation
criterion was based on the saturation of open codes, as there was
evidence of repeated coding within the same codes.
Data analysis was facilitated by the use of Nvivo9 software to
manage transcripts, themes and quotes, while keeping in mind the
context of the quotes within individual interviews.
Results
Sample Characteristics
A total of 21 patients were interviewed between January 2011
and February 2012 from five different healthcare locations (one
public hospital-based primary care clinic, three public health
clinics, and one private clinic). Table 2 details the range of patients
interviewed. Although most patients were from an urban setting,
they came from diverse socio-economic background. We achieved
good variation in our sample in terms of healthcare setting,
patients’ decision about starting insulin, and ethnicity. Three core
categories of themes emerged: 1) Insulin-specific values, 2) Life
goals and philosophies and 3) Socio-cultural values and personal
background.
Treatment-specific Values
When making decisions whether or not to start insulin, patients
had specific beliefs and feelings about insulin (treatment-specific
values). Examples of participants’ perceived advantages and
disadvantages of insulin are reported in Table 3.
Beliefs about insulin. The most commonly mentioned
advantage was that insulin would help control diabetes and thus
prevent diabetes complications. Some thought that insulin would
replace oral glucose-lowering tablets (fewer medications) while
others believed that insulin had fewer side-effect than tablets.
Furthermore, some were reluctant to increase their daily number
of oral tablets. One participant had the misperception that insulin
was only injected once a week.
However, the majority of participants had negative perceptions
about insulin. They expressed doubt over the origin of insulin;
concern over insulin side-effects (e.g. hypos); believed that insulin
might cause kidney failure and impair pancreatic function. Cost of
insulin was also a concern for patients from poor socio-economic
backgrounds and private patients whose insulin was subsidised by
their employers.
When I am working, the cost (of insulin) can probably be
covered. But, when I’m not working? Who wants to cover?
Like I say, insulin isn’t bad, it’s good. But, it’s the cost. Cost
and for me, how long you want to stick to that kind of
medicine. It’s expensive, I know, and that one (insulin) is
indeed expensive.
F9, female, 43 years old (y.o.), private general practice.
Moreover, patients had injection-related concerns including:
pain, fear of needle, scarring from injections, lifestyle interference,
infection at injection sites, forgetting to inject and insulin storage.
Some participants were not aware that finer, less-painful needles
were available. Two participants were afraid that the needle would
break during injections.
Feelings about insulin. Participants also reported positive
and negative affection about starting insulin. When advised to start
insulin, some patients felt that their diabetes was worsening while
others denied the need for insulin. They were not confident to self-
inject; there was a sense of frustration or personal failure and felt
that they were being punished for not controlling their diabetes.
Conversely, some had a more positive affection about insulin
Table 1. Semi-structured interview topic guide and corresponding value attribute in Schwartz’s Theory of Values.
Interview questions
Corresponding value attribute in Schwartz’s Theory of Values (if
any)
Part 1: Introduction and rapport building
Q1. Can you tell me about your history of diabetes
Part 2: Focusing on beliefs about insulin and values
Q2. Have you been asked to start insulin? By whom?
Q3. What has been going through your mind since you were advised to start insulin? Values are concepts or beliefs. We probed the patient’s beliefs about
insulin such as negative or positive perceptions, and sources of beliefs.
Q4. Where do you get your ideas/beliefs about insulin from?
Q5. Is starting insulin a difficult decision for you? Why or why not? Values guide selection or evaluation of behaviour and events. We
explored if patients were motivated to start or avoid insulin and their
reasons for doing so.
Q6. Are you motivated to start insulin? Why or why not?
Q7. Have you received any information about starting insulin?
Q8. What are important priorities to you at this stage of life? Values pertain to desirable end states or behaviours. We explored
patients’ life priorities as an operational definition of desirable end states.
Q9. Do these influence your decision to start insulin? If yes, how so? If no, why not? Values are ordered by relative importance. We probed if patients
valued some priorities over others, and if priorities had changed over time
with different stages in life.
Values transcend specific situations.We explored if non-health related
priorities influenced patients’ decisions about insulin.
doi:10.1371/journal.pone.0080051.t001
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initiation. They considered insulin initiation as a natural disease
progression. They also gained confidence in insulin therapy by
discussing with peers who used insulin.
Life Priorities and Philosophies
When asked what was important in life that might influence
their decision making, the participants’ responses could be coded
into two categories: life priorities and general philosophies.
Life Priorities
Life priorities were specific goals in life. Three types of life
priorities emerged from the interviews: health, finance and career.
Health. Health was a major priority for four participants.
Two participants said that health was more important than
finance. They said, ‘‘It’s OK, we can spend a lot of money. Waste
money even, if it’s to look for medicine. We want to look after our
body.’’ (M4, male, 53 y.o., public health clinic) and ‘‘Even if I have
a lot of money, if we are not healthy, it’s unacceptable’’ (M7, male,
67 y.o., public hospital-based clinic). One patient said that
awareness of risk of diabetes complications ‘‘puts you at fear,
[you could be that close to] death’’ (M9, male, 28 y.o., public
hospital-based clinic).
Career/Employment. Interviews with patients who put
priority on career or employment served to illustrate how different
patients expressing a similar priority could frame insulin either
positively or negatively. For example, one patient viewed insulin
positively as he believed it helped him to control blood glucose
spikes that had hindered his concentration during work. The other
patient viewed insulin negatively as it would interfere with his work
schedule.
‘‘Establishing myself in terms of career …my sugar is under
control and then I can still hope for the future in terms of
careers prospects because I don’t get the sugar spikes
anymore, you know’’ (positive view of insulin).
M9, Male, 28 y.o., public hospital-based clinic.
‘‘I feel good if I go to work…it’s difficult for me to take
insulin in the morning, because I have to leave for work at 5
am. We have to think about this as well.’’ (negative view of
insulin).
M6, Male, 57 y.o., public health clinic.
Finance. Finance was a priority mentioned by three patients.
Insulin-related costs were a concern for them. The need for a self-
monitoring blood glucose (SMBG) meter caused one patient to
say, ‘‘My priority is surely (pause) finance. Doctor A told me to buy
the diabetes monitor; she said it’s sold here. The problem is…I
can’t afford it. It’s hard being a taxi driver, because taxi rental is
fifty ringgit (GBP 10) everyday’’ (M5, male, 44 y.o., public health
clinic).
Hierarchy of life priorities. A hierarchy of priorities existed
for participants. For example, health was more important than
finance. However, priorities were sometimes co-related; one
participant reasoned that health was important because it helped
to achieve her financial goals.
Table 2. Characteristics of participants. Values are numbers unless stated otherwise.
Characteristic Participants (n=21)
Male 12
Mean (SD) age (years) 55.24 (9.14)
Age range (years) 28–67
Status of insulin use
Not currently on insulin 13
Already using insulin 8
Healthcare setting
University hospital based primary care clinic 7
Public healthcare clinics 8
Private clinic 6
Language used during interview
Malay 9
English 10
Chinese 2
Ethnicity
Malay 6
Chinese 5
Indian 10
Decision about insulin
Keen to start insulin 10
Not keen to start insulin 8
Undecided 1
Not applicable (previous insulin users- gestational diabetes (n = 1) and short-term insulin use(n = 1)) 2
doi:10.1371/journal.pone.0080051.t002
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‘‘I was thinking, like, if I want to save my money, I must take
care of my health. Hah, that’s why I go for exercise, you see.
Exercise is important. And diet. That’s my concerns.’’
F9, female, 43 y.o., private general practice.
Life Philosophies
Some patients framed insulin according to their life philosophy.
In contrast to life priorities, which are concrete goals that are
important to the patient, life philosophies are related to patients’
worldviews and ethical beliefs about what are morally desirable.
Avoiding suffering. Avoiding suffering was a recurring
theme. One participant stated that his view on life was to ‘‘die
happy’’ and that he would consider taking insulin because he
didn’t want to ‘‘suffer and die’’ (M3, male, 63 y.o., public health
clinic).
Another said that ‘‘If my suffer(ing)s are very major, I’m going
to be dependent on anybody, I might as well go kill myself, instead
of living with all the suffering and whatever nonsense that’s going
on.’’ (M10, male, 55 y.o., public hospital-based clinic).
Another participant associated suffering with death by saying
she prayed that ‘‘Please help me, I don’t want to suffer pain. If I
live, just let me live normally. When I die, don’t let me suffer pain
or anything, don’t let me die that way’’ (F6, female, 56 y.o., public
hospital-based clinic).
Fatalism. Some participants refused insulin treatment as they
felt that everyone was fated to die one way or another.
‘‘About dying, I’m not worried about it because these things
they come naturally. Die means you die, no helping it. You
inject until he dies, also die in the end, it’s like that. So there
is nothing to worry about.’’
M8, male, 60 y.o., private general practice.
Not being a burden. Not burdening others was the most
important philosophy for one lady. She explained that ‘‘I don’t
want to be a burden to anybody and as well as to myself. I want to
be independent, and a helpful person. That’s the thing that’s
making me agree to insulin’’ (F4, 61 y.o., public hospital-based
clinic).
Socio-cultural Values and Personal Background
Patients’ decision to start insulin was also shaped by their larger
social environment, belief system (e.g. religion), and personal
background (e.g. family context).
Religion. Religious values were a factor that influenced
patients’ views about insulin. Four participants were concerned
that the use of insulin might conflict with their religious beliefs. A
Muslim patient was concerned about the purity (‘halal’) of insulin
and needed assurance from a Muslim clinician. A Hindu patient
illustrated how insulin injections could potentially desecrate holy
sites as religious rules forbade blood being spilt inside temples.
I wouldn’t like to be in a (Hindu) temple, take out my needle
and jab, I don’t think it’s nice. Because that’s supposed to be
a spiritual, clean place. So my son-in-law was, like, arguing
with me that day and said the blood doesn’t come out. In a
spiritual place, blood shouldn’t come out as if it will fall on
the floor of the temple, it’s a very big (pause) sin.
F4, female, 61 y.o., public hospital-based primary care
clinic.
Personal and family background. The following example
illustrates how a 66 year-old woman’s family context influenced
her decision to avoid insulin. For this patient, her insulin-specific
belief was the perception that insulin was expensive.
‘‘I feel I want to save money. Insulin is expensive; I don’t
want to take it.’’
F5, female, 66 y.o., public hospital-based clinic.
When asked what was important to her in life, she said that her
life priority was on work. This was related to her view that her
children were unable to support her.
‘‘I am mostly thinking about work. My son in law,
children…how much money can they give? My daughter
has her own family, my son also has his own family.’’
Finally, when probed why work was prioritised, it emerged that
this was due to her tight financial situation. She had to work to
support her family and provide for her children’s studies after her
husband became ill.
‘‘I suffer a lot. My husband retired at fifty-five. Because the
doctor asked him to stop working, that time he has a heart
problem. That’s why every cent I earned, I give it to my son
and daughter to study.’’
Discussion
This study aimed to explore patient values and what role it plays
when making a health decision. The study identified a range of
patients’ positive and negative perceptions of insulin as well as life
priorities and philosophies that influenced patients’ decision
making. Through analysis of patient narratives, we illustrate how
patients’ personal background also influenced their decision about
insulin. The study expands the current definition of patient values
as treatment preferences to cover a broader dimension including
personal life goals and philosophies.
The strength of this study is that the theoretical framework was
drawn from a social science theory of human values. By
broadening our scope of values to those outside of healthcare,
we illustrate how priorities such as career achievement and ethical
convictions are influential in patient decision making. Thus, the
complex interactions between treatment-specific beliefs, goals and
contextual background that emerged from the data are more
holistic and, we believe, provide a more accurate representation of
actual patient values.
The limitations of our study are that the specific themes from
this study may not be transferable to other conditions. Patient
values are shaped by local culture and norms. Therefore, priorities
and philosophies identified in this sample of patients may not be
similar to patients elsewhere.
The first category of values comprised of beliefs and feelings
about insulin. These influenced patients’ view of insulin as being
either positive or negative. Firstly, patients have a set of cognitive
beliefs about the perceived advantages and disadvantages of
insulin (refer to Table 3). Not all of these beliefs are correct;
patients also reported misperceptions about insulin. Besides
cognitive concepts of insulin, patients also expressed an affective
concept of insulin i.e. how insulin made them feel. Denial,
Patient Values in Medical Decision Making
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Table 3. Beliefs and feelings about insulin.
Themes Participant quotes
BELIEFS ABOUT INSULIN
Positive beliefs about insulin
Improve control of diabetes ‘‘To me, I feel that maybe the (oral) drug does not help, then have to use the insulin. I was
prepared because I see that my reading, ah, never come down’’ F8, female, 57 y.o., private
general practice
Prevent diabetes-related complications ‘‘So I’m thinking, if I’m sixty years old, how long more can I live? Can I put ten more years, can I
put twenty years? So why wait till, you know, when my diabetes is very bad and then put full
dose of insulin. Try it now and see.’’ F4, female, 61 y.o., public hospital-based primary care clinic.
Minimal side-effects ‘‘Insulin is what our body is producing, you see, rather than all these chemicals going into the
body. So it’s just that we take the insulin, it’s easy, direct, no…side effects. I mean, there
should be minimal side effects.’’ F4, female, 61 y.o., public hospital-based primary care clinic.
Enable the patient to lead normal lifestyle ‘‘[The doctor] said we give you insulin, means you can eat, no need to control (your diet). You
don’t want to eat, or you want to eat, this (insulin) is better. That’s why I said, straightaway
said I want it’’ M3, male, 63 y.o., public health clinic.
Convenience of once-daily injections ‘‘[Insulin] is convenient. If you’ve injected in the morning then at night you don’t have to
inject’’ M12, 61 y.o., private general practice
Medication adherence is improved ‘‘But if you take insulin every day, you won’t forget. Tablets sometimes you forget. Insulin you
know that when you wake up in the morning, you have to inject. Oh, it’s time to eat, it’s time
to inject. For tablets, you’re working, working, working and then you have this tablet and that
tablet, take half hour after meal, you forget. You go to a restaurant, at that time, you take your
tablets, and you need water, right? Ah, you have to look for water. For him (insulin-users) you
don’t have to, no need to look for water, just inject insulin.’’ F6, female, 58 y.o., public hospital-
based clinic
Negative beliefs about insulin
Injection-specific beliefs
Scarring ‘‘I don’t want to start the insulin. My main concern is the injection and the scar. Everyday
injecting, you know, I’m worried it will leave a scar. Because, diabetic people, when you have
small injuries, you’ll get black scars, I think my legs have got some. ’’ M10, male, 55 y.o., public
hospital-based clinic
Risk of infections ‘‘I’m afraid of, if I start injections tomorrow, will I get any side-effects? Usually, for people with
diabetes, when they get a wound, it gets infected, right? Ah, I’ve seen a friend, his leg got cut
by a wire, infected and pus-filled.’’ M7, male, 67 y.o., public hospital-based clinic
Easier to forget to take injections ‘‘And then, if they (people who take insulin) missed one day, also it’s a problem. So that’s the
reason why I don’t want to take insulin, I’ve been taking medicine for all this while. Medicine is
a habit to me, every day I take, I’m reminded to take. Insulin, no, I mean, you might forget.’’
M10, male, 55 y.o., public hospital-based clinic
Interference with current lifestyle ‘‘The way the nurses, the dieticians and the diabeticians and the doctors told me look you
must align yourself so they have here 4 meals or 3 meals or whatever and the insulin jabs
would correspond to meals. I never take regular meals and the thing is like um… when we
have problem with diabetes it’s simply because we cannot cope with that huge amount of
glucose in our body so human beings physiologically shouldn’t eat big meals you see we only
supposed to have small parts throughout the day. But that was what I was trying to do and
then the way that they told me is just that…is contrary to what I’ve been doing.’’ M1, male,
47 y.o., public hospital-based clinic
Injection- and needle-phobia ‘‘It’s just that the jabs bothered me at that time. The thing is I don’t like poking myself… that’s
normal and the thing is you know like uh… you… doing it 4 times a day you know it’s not
easy and I mean it was like you have to do it really… I mean sort of like I don’t know you have
to have a very good angle to it and then you won’t feel anything and there are some parts
that you, there are some places where you cannot just push it through.’’ M1, male, 47 y.o.,
public hospital-based clinic
‘‘I’m really afraid of needles. And my daughter told me, how about the needles, right. It’s tiny,
you better be careful, if it breaks.’’ F3, female, 48 y.o., public health clinic
Preference for oral tablets or lifestyle intervention ‘‘I feel that I can control my own body. That’s all I think about. When I can’t control (my
diabetes), my body doesn’t have enough exercise, that’s the time that I will take insulin. So,
now, I have enough exercise, I can control. That’s all.’’ M6, male, 56 y.o., public health clinic.
Social stigma attached to injections ‘‘Will I look like a drug addict? That’s the reason I don’t want to take insulin. It’s just like a drug
addict, you know, on the road. They inject themselves, you know, to make them high. This
insulin also you have to inject yourself. So you look like a drug addict. I’m not a drug addict,
because I only smoke, that’s the only thing I do. So I don’t want to go into the stage where
injection, injection, injection.’’ M10, male, 55 y.o., public hospital-based clinic
Insulin-specific beliefs
Unsure about the origin ‘‘I think, quite a number of my friends were not, maybe SPM (high-school) level ah, don’t know
that insulin is a natural body made product. They think it’s a very strong medicine, that kind of
attitude.’’ F4, female, 61 y.o., public hospital-based clinic
Patient Values in Medical Decision Making
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punishment or lack of self-efficacy would influence patients to view
insulin negatively.
Our study reports that patients in Asia share similar beliefs
about insulin as those in the west, such as the fear of injections
[31,32], inconvenience when using insulin [17,33], fear that
insulin will cause organ damage [32,34], and feeling a sense of
failure or punishment [32,35]. However, while most studies only
highlight medically-related barriers concerning the efficacy and
side-effects of insulin [36], our study underlines the importance of
exploring non-medical beliefs as potential barriers during insulin
initiation. Some examples in our study include religious beliefs
about blood, and patients’ fear of social stigma from associating
drug use with injection scars. Such socio-cultural and religious
concerns may be factors for higher insulin refusal rates in Asian
populations (42–52%) [36,37,38] compared to the west.
Besides insulin-specific beliefs, other non-health beliefs also
influenced patients’ decisions. Patients would consider if insulin
agreed with their system of life goals and philosophies. In other
words, the choice about insulin was interpreted according to the
patient’s worldview. Previous literature has highlighted different
types of patient values that should be considered when making a
healthcare decision [39]. Schwartz et al have reported that from a
list of seven ‘life goals’ (family, wealth, job, education, health/
fitness, travel, and personal fulfilment), participants were signifi-
cantly more willing to trade off achieving family goals for health or
life years compared to other goals [40]. Such value typologies
however face the limitation of being either conceptual or
hypothetical. Our study adds to the literature by reporting on
patients actually used values when considering insulin. Besides
weighing the pros and cons of insulin from a medical perspective,
patients also viewed if insulin would be congruent with their
worldview, which includes their life goals and philosophies.
Implications for Practice
Currently, patient education remains the cornerstone of
counselling patients who are resistant to insulin [41,42,43]. The
majority of the interventions focus on motivating patients to start
insulin by changing their perceptions about insulin (e.g. normal-
ization of insulin) and challenging negative perceptions about
insulin use. There is little discussion about decision support and
whether the treatment agrees with patients’ values. One reason for
this is the assumption that both HCPs and patients share similar
values [39]. This study shows that patient values may not be
congruent with health-seeking goals. Thus, besides addressing
patients’ negative perceptions, HCPs must also explore patients’
underlying value motivations [44].
From our analysis, patient values comprise three key categories:
treatment-specific values; life priorities and philosophies; and
socio-cultural and personal background. In Figure 1 we propose a
conceptual model whereby these components form the content of
the model and are arranged in three layers. The need to elicit
patient values in medical decision making arises within the context
Table 3. Cont.
Themes Participant quotes
Damaged organs ‘‘I told (my friends) I got to take injections and all that. They err, they said, you inject here, the
behind gets spoilt. (Interviewer: Behind? Kidneys?). Yeah, sooner or later its spoilt. My aunties
use it, injections. They said kidneys have a lot of problem. That’s why they say, just take oral
tablets. Don’t take injections, just eat medication, let go of bad habits, reduce your food and
all that.’’ M4, male, 53 y.o., public health clinic
Fear of hypoglycemic events [Interviewer: So previously, was it your work that caused you to stop insulin?] No, it was the
sweat, I have the sweat. So every night, I have to…shivering and wake up. So I was panic, you
know. So I stopped it.’’ M11, male, 57 y.o., private general practice
FEELINGS ABOUT INSULIN
Positive feelings about insulin
Normalization ‘‘Insulin is better, I think so, means, I’ll recommend insulin. Because now I see all the people
taking insulin, later on, I also take, it’s better.’’ M3, male, 63 y.o., public health clinic
Acceptance ‘‘So I have no choice in that (insulin)…and it’s just that when they found that the levels were
not good, that’s when they said it would be better to start on the insulin. Because they gave
this very good analogy saying that it is like throwing salt into the sea. You see… when you
throw salt into the sea there’s no effect. So that’s the kind of analogy…so I have to change.’’
F1, female, 58 y.o., public hospital-based clinic
Negative feelings about insulin
Severity of diabetes ‘‘My response (to starting insulin) was that my diabetes was not that serious ah. As I said, I will
not take it for the time being, I want to observe for a while and see how it goes. [Interviewer:
You feel, that if other people take insulin, under what conditions do you think it is important
to take insulin?] It is very serious already, when no cure from medicine, then only take this
insulin, isn’t it?’’ M8, male, 60 y.o., private general practice
Denial (patient had been advised by doctor to start insulin) ‘‘[Interviewer: So, it was Dr. H who asked you to start insulin, right?] Patient: No, he didn’t, he
didn’t. [Interviewer: Oh…sorry.]’’. M11, male, 57 y.o., private general practice
Frustration or failure ‘‘I think it’s basically attitude change but it’s rather a difficult step lah, that transition (to
insulin) was difficult. For me, it’s like failing an exam. I tried with so many medications as each
time she increases the medications I get depressed. Very sad, ah, it’s getting bad, it’s getting
bad.’’ F4, female, 61 y.o., public hospital-based clinic
Feeling punished or threatened ‘‘She (the doctor) say…she scare, she want to scare me. She said, ‘‘So high your reading! 10
point something, just now it was like that. 10 point something, you so high, I must put you on
insulin all that’’. I said, please don’t do that, I say.’’ F5, female, 66 y.o., public hospital-based
clinic
doi:10.1371/journal.pone.0080051.t003
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of a specific medical decision. As such, the arrangement of the
layers in the model was based on how closely related the value
categories were to the medical decision being discussed. Whereas
the first layer (treatment-specific values) are beliefs that are specific
to the treatment (e.g. ‘‘I am afraid of insulin injections because
they are painful.’’), the second (life priorities and philosophies) and
third (socio-cultural and personal background ) layers are trans-
situational, meaning that they are applied to other areas besides
health. The second layer is the patient’s personal, individual beliefs
(which may also include health as a priority) while the third layer
comprises cultural and contextual influences. This model expands
on the current scope of patient values in EBM [1,12] and SDM [5]
to also include life priorities and philosophies (or a patient’s
worldview). In the centre are treatment-specific beliefs which
depend on the medical context, while layers further from the
centre are more deep-seated and trans-situational, and more
importantly, also influence the treatment choice.
Recent literature has expressed the need to consider the broader
communicative and relational contexts when practicing SDM
[45]. When supporting patients in making decisions, clinicians
need to address more than just beliefs and feelings about the
treatment options. A deeper understanding of patients’ life
priorities and background are essential, particularly when making
decisions about treatments. From our study, we suggest that
assessing these values involves competencies in eliciting and
analysing patient narratives [46,47,48,49]. Understanding patient
narratives is especially important for long-term care of chronic
diseases which are heavily influenced by factors such as prior and
current life experiences, resources, and explanatory models of
illness [50].
Further research needs to be done on a number of aspects.
Firstly, how generalisable is the proposed conceptual model of
patient values? More studies should be conducted in different
healthcare decisions, locations and cultures. Secondly, would an
intervention targeting goals and philosophies be more effective
than management programmes focusing on improving patient
perceptions about insulin? One example would be value self-
confrontation, [51] where a patient with poor glycaemic control
could be shown how their set of values differs from that of patients
with good glycaemic control.
Conclusions
In this paper, we introduce a comprehensive model of patient
values based on actual patient perspectives. This model fits well
with the practice of EBM and SDM by helping clinicians to
understand how patients also consider other non-health values
when making a treatment decision. Further study needs to be done
to explore the applicability of this model in other contexts.
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